Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Related Posts

FPX Nickel Announces Results of 2025 Annual General...

June 28, 2025

Appointment of Managing Director

July 29, 2025

December 2024 Quarterly Results Presentation

January 29, 2025

Silver Price Surges to US$37, Highest Value Since...

June 18, 2025

Placement Prospectus

December 11, 2024

Blackstone Minerals

July 25, 2025

Alkane-Mandalay Merger Paves Way for New Aussie Gold...

May 1, 2025

Gold vs. Copper: Which Metal Will Shine Brighter...

March 11, 2025

Standard Uranium

November 13, 2025

TSX Hits Record High Amid Gold Price Surge...

May 21, 2025

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio
  • Capitol police arrest Rubio hearing disruptor, as Republican senator says ‘off to jail’
  • Trump calls on employers nationwide to match contributions into workers’ kids’ Trump Accounts
  • Rubio warns NATO allies US is ‘not simply focused on Europe,’ doesn’t have unlimited resources

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    January 29, 2026
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    January 29, 2026
  • Capitol police arrest Rubio hearing disruptor, as Republican senator says ‘off to jail’

    January 29, 2026
  • Trump calls on employers nationwide to match contributions into workers’ kids’ Trump Accounts

    January 29, 2026
  • Rubio warns NATO allies US is ‘not simply focused on Europe,’ doesn’t have unlimited resources

    January 29, 2026
  • Gulf shipping operations grind to halt near Iran, US quietly prepares for possible strike: ‘Heightened risk’

    January 29, 2026

Editors’ Picks

  • 1

    Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

    September 19, 2025
  • 2

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 3

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 4

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 5

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 6

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 7

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
Promotion Image

banner

Categories

  • Business (607)
  • Investing (2,913)
  • Politics (3,568)
  • Stocks (1,054)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Copyright © 2026 bullhedging.com | All Rights Reserved